{"id":"https://openalex.org/W7214520874","doi":"https://doi.org/10.7759/cureus.117018","title":"Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report","display_name":"Isolated Oral and Esophageal Mucosal Injury as a Rare Oxcarbazepine Adverse Drug Reaction: A Case Report","publication_year":2026,"publication_date":"2026-09-27","ids":{"openalex":"https://openalex.org/W7214520874","doi":"https://doi.org/10.7759/cureus.117018","pmid":"https://pubmed.ncbi.nlm.nih.gov/42948823","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13712895"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.117018","doi":"https://doi.org/10.7759/cureus.117018","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117018","pdf_url":"https://www.cureus.com/articles/524436-isolated-oral-and-esophageal-mucosal-injury-as-a-rare-oxcarbazepine-adverse-drug-reaction-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/524436-isolated-oral-and-esophageal-mucosal-injury-as-a-rare-oxcarbazepine-adverse-drug-reaction-a-case-report.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120132311","display_name":"Joselyn De Jesus-Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joselyn De Jesus-Gonzalez","raw_affiliation_strings":["Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071496556","display_name":"Quinten P. Federico","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Quinten P Federico","raw_affiliation_strings":["Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, USA","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153103631","display_name":"Patrick Malafronte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801973574","display_name":"Tampa General Hospital","ror":"https://ror.org/03tj5qd85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801973574"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Malafronte","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, Tampa General Hospital, Tampa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Tampa General Hospital, Tampa, USA","institution_ids":["https://openalex.org/I2801973574"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077658955","display_name":"Anne L. Champeaux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Champeaux","raw_affiliation_strings":["Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida, Tampa, USA","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075996659","display_name":"Narayanan Shreya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shreya Narayanan","raw_affiliation_strings":["Division of Digestive Disease and Nutrition, Morsani College of Medicine, University of South Florida, Tampa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Digestive Disease and Nutrition, Morsani College of Medicine, University of South Florida, Tampa, USA","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108631600","display_name":"John Jacobs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Jacobs","raw_affiliation_strings":["Division of Digestive Diseases and Nutrition, Joy McCann Culverhouse Center for Swallowing Disorders, Morsani College of Medicine, University of South Florida, Tampa, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Digestive Diseases and Nutrition, Joy McCann Culverhouse Center for Swallowing Disorders, Morsani College of Medicine, University of South Florida, Tampa, USA","institution_ids":["https://openalex.org/I2613432"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5120132311"],"corresponding_institution_ids":["https://openalex.org/I2613432"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.65766221,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"9","first_page":"e117018","last_page":"e117018"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11452","display_name":"Oral Health Pathology and Treatment","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/3500","display_name":"General Dentistry"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oxcarbazepine","display_name":"oxcarbazepine","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8289999961853027},{"id":"https://openalex.org/keywords/esophagitis","display_name":"esophagitis","score":0.8259999752044678},{"id":"https://openalex.org/keywords/oral-mucosal-ulcers","display_name":"oral mucosal ulceration","score":0.9139999747276306},{"id":"https://openalex.org/keywords/oral-mucositis","display_name":"oral mucositis","score":0.8650000095367432},{"id":"https://openalex.org/keywords/drug-induced-mucosal-injury","display_name":"drug-induced mucosal injury","score":0.8209999799728394},{"id":"https://openalex.org/keywords/naranjo-score","display_name":"Naranjo score","score":0.7990000247955322},{"id":"https://openalex.org/keywords/antiepileptic-drug-toxicity","display_name":"antiepileptic drug toxicity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7400000095367432},{"id":"https://openalex.org/keywords/medication-review","display_name":"medication review","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9894999861717224},{"id":"https://openalex.org/C2781176495","wikidata":"https://www.wikidata.org/wiki/Q176301","display_name":"Oxcarbazepine","level":4,"score":0.7534999847412109},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6460999846458435},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.569100022315979},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.557200014591217},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5223000049591064},{"id":"https://openalex.org/C2777819096","wikidata":"https://www.wikidata.org/wiki/Q173710","display_name":"Esophagus","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.3472000062465668},{"id":"https://openalex.org/C2994127763","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Antiepileptic drug","level":3,"score":0.2937000095844269},{"id":"https://openalex.org/C2780323790","wikidata":"https://www.wikidata.org/wiki/Q2912193","display_name":"Esophageal disease","level":3,"score":0.2824000120162964},{"id":"https://openalex.org/C2778866283","wikidata":"https://www.wikidata.org/wiki/Q3257565","display_name":"Endoscopic mucosal resection","level":3,"score":0.28110000491142273},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26579999923706055}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.117018","doi":"https://doi.org/10.7759/cureus.117018","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117018","pdf_url":"https://www.cureus.com/articles/524436-isolated-oral-and-esophageal-mucosal-injury-as-a-rare-oxcarbazepine-adverse-drug-reaction-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13712895","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13712895/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13712895/pdf/cureus-0018-00000117018.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:42948823","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42948823","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.7759/cureus.117018","doi":"https://doi.org/10.7759/cureus.117018","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.117018","pdf_url":"https://www.cureus.com/articles/524436-isolated-oral-and-esophageal-mucosal-injury-as-a-rare-oxcarbazepine-adverse-drug-reaction-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214520874.pdf","grobid_xml":"https://content.openalex.org/works/W7214520874.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1143185986","https://openalex.org/W1968205500","https://openalex.org/W2041090550","https://openalex.org/W2085367492","https://openalex.org/W2138112164","https://openalex.org/W2611564992","https://openalex.org/W2888276484","https://openalex.org/W3114177164","https://openalex.org/W3199203413","https://openalex.org/W3201668017","https://openalex.org/W3203255903","https://openalex.org/W4213380138","https://openalex.org/W4223992728","https://openalex.org/W4381547700","https://openalex.org/W4399512862","https://openalex.org/W4405273318","https://openalex.org/W4406063493","https://openalex.org/W4412788631"],"related_works":["https://openalex.org/W7130649233","https://openalex.org/W2582256188","https://openalex.org/W2401148998","https://openalex.org/W4223992728","https://openalex.org/W2946443585","https://openalex.org/W4327519779","https://openalex.org/W4404997550","https://openalex.org/W4391338217","https://openalex.org/W2192098797","https://openalex.org/W1499431720"],"abstract_inverted_index":{"Drug-induced":[0],"mucosal":[1,26,51],"injury":[2,27],"may":[3],"result":[4],"from":[5,68],"direct":[6],"contact":[7],"toxicity":[8],"or":[9,30,88,98,125],"immune-mediated":[10],"adverse":[11,110,148],"drug":[12,111,149],"reactions.":[13],"Although":[14],"oxcarbazepine":[15,57,118],"is":[16],"a":[17,40,108],"recognized":[18,144],"etiology":[19],"of":[20,65,85,105,115,117,146,155],"severe":[21,45],"hypersensitivity":[22],"reactions,":[23],"isolated":[24],"oroesophageal":[25],"without":[28,120],"cutaneous":[29],"systemic":[31,99],"involvement":[32],"has":[33],"not":[34],"been":[35],"previously":[36],"described.":[37],"We":[38],"report":[39],"68-year-old":[41],"woman":[42],"who":[43],"developed":[44],"diffuse":[46,162],"esophagitis":[47,163],"with":[48,59,82,161],"concomitant":[49],"oral":[50,165],"ulceration":[52],"approximately":[53],"two":[54],"weeks":[55],"after":[56],"initiation,":[58],"symptom":[60],"onset":[61],"within":[62],"24":[63],"hours":[64],"dose":[66],"escalation":[67],"150":[69],"to":[70],"300":[71],"mg":[72],"twice":[73],"daily.":[74],"Histologic":[75],"evaluation":[76],"demonstrated":[77],"predominantly":[78],"lymphocytic":[79],"esophageal":[80],"inflammation":[81],"no":[83,94],"evidence":[84],"infectious,":[86],"eosinophilic,":[87],"immunobullous":[89],"disease.":[90],"The":[91],"patient":[92,133],"had":[93],"rash,":[95],"peripheral":[96],"eosinophilia,":[97],"organ":[100],"involvement.":[101],"A":[102],"Naranjo":[103],"score":[104],"7":[106],"supported":[107],"probable":[109],"reaction.":[112],"Treatment":[113],"consisted":[114],"discontinuation":[116],"alone,":[119],"the":[121,132,143,153],"need":[122],"for":[123],"immunosuppressive":[124],"additional":[126],"pharmacologic":[127],"therapy.":[128],"At":[129],"five-month":[130],"follow-up,":[131],"achieved":[134],"endoscopic":[135],"and":[136,151,164],"histologic":[137],"resolution.":[138],"This":[139],"case":[140],"expands":[141],"upon":[142],"spectrum":[145],"oxcarbazepine-associated":[147],"reactions":[150],"emphasizes":[152],"importance":[154],"medication":[156],"review":[157],"in":[158],"patients":[159],"presenting":[160],"mucositis.":[166]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-09-28T00:00:00"}